Adjuvant radiotherapy and radiochemotherapy in the management of esophageal cancer: a review of the literature.
Surgical resection remains the mainstay treatment for esophageal cancer and the failure of surgery alone is attributed to the systemic nature of the disease at the time of presentation. In an effort to improve local control of the disease that should correspond to a benefit in survival, postoperative adjuvant schemes of treatment have been explored. Current standard treatment, and future implications in light of the new knowledge are analyzed, based on the present literature. The possibility of different treatments in relation to different histology findings, is stressed.
Carcaterrra
Maurizio
M
U.O.C. Radioterapia Oncologica, Università La Sapienza, Roma, Italy. maurizio.carcaterra@uniroma1.it
Osti
Martia Falchetto
MF
De Sanctis
Vitaliana
V
Caruso
Cristina
C
Berardi
Francesca
F
Enrici
Riccardo Maurizi
RM
D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D004938:Esophageal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery*; D006801:Humans; D009367:Neoplasm Staging; D011379:Prognosis; D018714:Radiotherapy, Adjuvant; D016032:Randomized Controlled Trials as Topic